ArticleJournal of hematology2018

Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia.

Francesco Rodeghiero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.